A trial at Optegra Eye Hospital Hampshire saw patients receive drop-free, bilateral surgery with pre-op consultation and ...

Steroids, commonly used to treat inflammation, asthma, allergies, arthritis, and autoimmune diseases, can pose a serious risk ...

And regarding the drop-free treatment, patient Maria Walmsey, 78, from Waterlooville said: “I understand that previously drops were always administered to keep the eye free from bacteria. And it has ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

Patients in both arms will be eligible for supplemental injections of aflibercept and will receive prophylactic steroid eye drops. ARTEMIS is the first of two planned Phase 3 registrational trials ...